dNTP Mix (2,5 mM)
Invitrogen™

dNTP Mix (2,5 mM)

Solución lista para su uso
Have Questions?
Número de catálogoCantidad
R725011 mL
Número de catálogo R72501
Precio (MXN)
-
Cantidad:
1 mL
Pedido a granel o personalizado

Invitrogen 2.5 mM dNTP (2'-deoxynucleoside 5'-triphosphate) Mix consists of a solution of all four nucleotides, dATP, dCTP, dGTP, and dTTP, each at a concentration of 2.5 mM. It is supplied in purified water and neutralized to pH 8.0 with NaOH. 2.5 mM dNTP Mix is suitable for use in a wide variety of molecular applications.

Applications

  • Traditional PCR
  • Sequencing
  • cDNA synthesis
  • Nick translation
  • TdT-tailing reactions
Para uso exclusivo en investigación. No apto para uso en procedimientos diagnósticos.
Especificaciones
Cantidad1 mL
Condiciones de envíoDry Ice
Concentración2,5 mM
Para utilizar con (aplicación)Standard PCR
FormularioLíquido
Etiqueta o tinteSin marcar
Unit SizeEach
Contenido y almacenamiento
1 ml (2 x 500 µl) contiene suficientes dNTP de 2,5 mM para 200 reacciones de PCR (50 µl cada una). Almacenar a -20 °C. Se garantiza la estabilidad durante 12 meses si se almacena correctamente.

Citations & References (1)

Citations & References
Abstract
Molecular emergence of acute myeloid leukemia during treatment for acute lymphoblastic leukemia.
Authors: Blanco J G; Dervieux T; Edick M J; Mehta P K; Rubnitz J E; Shurtleff S; Raimondi S C; Behm F G; Pui C H; Relling M V;
Journal:Proc Natl Acad Sci U S A
PubMed ID:11526240
Therapy-related acute myeloid leukemias (t-AML) with translocations of the MLL gene are associated with the use of topoisomerase II inhibitors. We established the emergence of the malignant clone in a child who developed t-AML with a t(11;19) (q23;p13.3) during treatment for acute lymphoblastic leukemia (ALL). The MLL-ENL and the reciprocal ... More